New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
07:04 EDTNURONeuroMetrix announces initial commercial shipment of SENSUS system
NeuroMetrix has initiated commercial shipment of its SENSUS Pain Management System which received final FDA clearance on November 28, 2012. SENSUS is a transcutaneous electrical nerve stimulator intended for the symptomatic relief and management of chronic intractable pain.
News For NURO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2015
07:07 EDTNURONeuroMetrix reports Q2 EPS (48c) vs (85c) last year
Reports Q2 revenue $1.22M, one estimate $9.8M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use